Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 29, 2025 - AbbVie announced the FDA approval of Rinvoq (upadacitinib), for the treatment of adults with giant cell arteritis.
Download PDF
Return to publications
